Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
11.47
-0.39 (-3.29%)
At close: Jan 2, 2026, 4:00 PM EST
11.52
+0.05 (0.44%)
Pre-market: Jan 5, 2026, 8:33 AM EST
Arvinas Market Cap
Arvinas has a market cap or net worth of $736.65 million as of January 5, 2026. Its market cap has decreased by -43.55% in one year.
Market Cap
736.65M
Enterprise Value
-41.65M
1-Year Change
-43.55%
Ranking
Category
Stock Price
$11.47
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $736.65M, an increase of 42.72%. That is a compound annual growth rate of 5.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 736.65M | -3.29% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |